Your browser doesn't support javascript.
loading
Mass Spectrometry-Based Biomarkers in Drug Development.
Robinson, Michelle R; Miller, Ronald A; Spellman, Daniel S.
Affiliation
  • Robinson MR; Pharmacokinetics, Pharmacodynamics and Drug Metabolism, Merck Research Laboratories, West Point, PA, USA.
  • Miller RA; Impact Analytical, Midland, MI, USA.
  • Spellman DS; Pharmacokinetics, Pharmacodynamics and Drug Metabolism, Merck Research Laboratories, West Point, PA, USA. daniel_spellman@merck.com.
Adv Exp Med Biol ; 1140: 435-449, 2019.
Article in En | MEDLINE | ID: mdl-31347063
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Mass Spectrometry / Biomarkers / Proteomics / Drug Development Type of study: Guideline / Prognostic_studies Language: En Journal: Adv Exp Med Biol Year: 2019 Document type: Article Affiliation country: United States Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Mass Spectrometry / Biomarkers / Proteomics / Drug Development Type of study: Guideline / Prognostic_studies Language: En Journal: Adv Exp Med Biol Year: 2019 Document type: Article Affiliation country: United States Country of publication: United States